Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.

@article{Han2014ClinicalOO,
  title={Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.},
  author={Seungyeup Han and Eunah Hwang and Sungbae Park and Uijun Park and Hyoungtae Kim and Wonhyun Cho},
  journal={Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation},
  year={2014},
  volume={12 5},
  pages={401-4}
}
OBJECTIVES The best treatment for end-stage renal disease is kidney transplant, but the shortage of donor organs has caused long waiting times for an appropriate organ allograft. The use of ABO-incompatible kidney transplant can be a valuable option to expand the donor pool. The purpose of the present study was to evaluate 13 patients who had successful ABO… CONTINUE READING